Uterine Adenolipoleiomyoma: A Rare Hamartomatous Lesion

article OA: closed CC0 ⤵ 1 in-corpus citation
AI-generated summary by gemini-2.5-flash-lite, 2026-06-07

This paper describes a rare intramural uterine lesion, termed adenolipoleiomyoma, composed of smooth muscle, adipose tissue, and various types of glands, likely representing a benign hamartomatous growth.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by qwen3.7-flash, 2026-09-02 · read from full text

This case report describes a rare, well-circumscribed intramural uterine mass identified as adenolipoleiomyoma. Histological analysis revealed the lesion consisted of smooth muscle, adipose tissue, and various glandular types including endometrial, endocervical, and tubal epithelium, all supported by typical endometrial stroma. The authors classify this entity as a benign hamartomatous lesion, noting it is only the second such case reported and the first located within the uterine wall. Crucially, the surrounding myometrium showed no evidence of adenomyosis, distinguishing this distinct pathological entity from more common mixed tumors. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

An apparently unique intramural uterine lesion is described for which we propose the name adenolipoleiomyoma. On gross examination, a well-circumscribed white intramural mass contained focal fatty areas. Histology showed the mass to be composed of smooth muscle, adipose tissue, and endometrial, endocervical, and tubal type glands. The endometrial glands were surrounded by typical endometrial stroma. There was no evidence of adenomyosis in the uterus outside the lesion. This is only the second report of such a lesion within the uterus and the first with an intramural location. We believe it to be a benign hamartomatous lesion.
Full text 903 characters · extracted from oa-doi-fallback · click to expand
Case Reports Uterine Adenolipoleiomyoma: A Rare Hamartomatous Lesion - W. Glenn McCluggage - P. Hamal - A. I. Traub - M. Y. Walsh International Journal of Gynecological Pathology 19(2):p 183-185, April 2000. Summary: An apparently unique intramural uterine lesion is described for which we propose the name adenolipoleiomyoma. On gross examination, a well-circumscribed white intramural mass contained focal fatty areas. Histology showed the mass to be composed of smooth muscle, adipose tissue, and endometrial, endocervical, and tubal type glands. The endometrial glands were surrounded by typical endometrial stroma. There was no evidence of adenomyosis in the uterus outside the lesion. This is only the second report of such a lesion within the uterus and the first with an intramural location. We believe it to be a benign hamartomatous lesion. Copyright © 2000 Lippincott Williams & Wilkins, Inc.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosis

MeSH descriptors

Leiomyoma Uterine Neoplasms Cervix Uteri Cervix Uteri Endometrium Endometrium Fallopian Tubes Fallopian Tubes Female Hamartoma Hamartoma Humans Leiomyoma Middle Aged Neoplasms, Adipose Tissue Neoplasms, Adipose Tissue Uterine Neoplasms

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

Cited by (1)

References (4)

Cited by (1)

Source provenance

europepmc
last seen: 2026-09-11T06:15:56.568227+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:13:41.710148+00:00
unpaywall
last seen: 2026-09-11T06:32:28.951138+00:00
License: CC0 · commercial use OK